Published in
Taylor & Francis, Inhalation Toxicology, 8(29), p. 356-365
DOI: 10.1080/08958378.2017.1366602
Links
Tools
Nonclinical safety assessment of SPX-101, a novel peptide promoter of epithelial sodium channel internalization for the treatment of cystic fibrosis
Journal article published in 2017 by
Matthew P. Walker,
Matt Cowlen,
Dale Christensen,
Mutsumi Miyamoto,
Phillip Barley,
Timothy Crowder
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
